Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Evidence of enhanced iron excretion during systemic phosphorothioate oligodeoxynucleotide treatment.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Evidence of enhanced iron excretion during systemic phosphorothioate oligodeoxynucleotide treatment.
Evidence of enhanced iron excretion during systemic phosphorothioate oligodeoxynucleotide treatment. J Toxicol Clin Toxicol. 2000; 38(4):383-7.
View in:
PubMed
subject areas
Cadmium
Chelating Agents
Copper
Dose-Response Relationship, Drug
Erythrocyte Count
Humans
Infusions, Intravenous
Iron
Iron Chelating Agents
Leukemia, Myeloid, Acute
Male
Metabolic Clearance Rate
Middle Aged
Myelodysplastic Syndromes
Oligodeoxyribonucleotides, Antisense
RNA, Messenger
Spectrophotometry, Atomic
Thionucleotides
Tumor Suppressor Protein p53
Zinc
authors with profiles
Michael R. Bishop